Clinical Trial Update: Postoperative Concurrent Chemoradiotherapy Combined With Endostar for High-risk Early Stage Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating postoperative concurrent chemoradiotherapy combined with Endostar for high-risk early-stage cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Cervical Neoplasms

Drugs mentioned

• Endostar (recombinant human endostatin)

Snippet

Sponsor: Nanjing Medical University | Conditions: Uterine Cervical Neoplasms | Phase 2 | Status: UNKNOWN